145 related articles for article (PubMed ID: 31988454)
1. Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
Wu X; Zhang X; Yu L; Zhang C; Ye L; Ren D; Li Y; Sun X; Yu L; Ouyang Y; Chen X; Song L; Liu P; Lin X
Oncogene; 2020 Mar; 39(12):2568-2582. PubMed ID: 31988454
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of zinc finger protein 367 exerts a tumor suppressive role in colorectal cancer by affecting the activation of oncogenic YAP1 signaling.
Lei T; Gao Y; Duan Y; Cui C; Zhang L; Si M
Environ Toxicol; 2021 Nov; 36(11):2278-2290. PubMed ID: 34351699
[TBL] [Abstract][Full Text] [Related]
4. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
[TBL] [Abstract][Full Text] [Related]
5. Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
Liu J; Li J; Chen H; Wang R; Li P; Miao Y; Liu P
J Cell Mol Med; 2020 May; 24(10):5786-5796. PubMed ID: 32281270
[TBL] [Abstract][Full Text] [Related]
6. HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.
Gupta P; Gupta N; Fofaria NM; Ranjan A; Srivastava SK
Cancer Lett; 2019 Feb; 442():68-81. PubMed ID: 30409762
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
8. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
9. Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway.
Wang Y; Liao R; Chen X; Ying X; Chen G; Li M; Dong C
Cell Death Dis; 2020 Jul; 11(7):520. PubMed ID: 32647142
[TBL] [Abstract][Full Text] [Related]
10. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.
Cheng Y; Hou T; Ping J; Chen T; Yin B
J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064
[TBL] [Abstract][Full Text] [Related]
11. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
12. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
Malin D; Strekalova E; Petrovic V; Rajanala H; Sharma B; Ugolkov A; Gradishar WJ; Cryns VL
Oncogene; 2015 Nov; 34(45):5626-34. PubMed ID: 25684139
[TBL] [Abstract][Full Text] [Related]
13. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer.
Zeng H; Li T; Zhai D; Bi J; Kuang X; Lu S; Shan Z; Lin Y
Int J Biol Sci; 2020; 16(12):2084-2093. PubMed ID: 32549756
[TBL] [Abstract][Full Text] [Related]
14. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
15. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
[TBL] [Abstract][Full Text] [Related]
16. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
17. YAP activation in melanoma contributes to anoikis resistance and metastasis.
Zhao B; Xie J; Zhou X; Zhang L; Cheng X; Liang C
Exp Biol Med (Maywood); 2021 Apr; 246(8):888-896. PubMed ID: 33307801
[TBL] [Abstract][Full Text] [Related]
18. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
[TBL] [Abstract][Full Text] [Related]
19. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation.
Jia X; Shi L; Wang X; Luo L; Ling L; Yin J; Song Y; Zhang Z; Qiu N; Liu H; Deng M; He Z; Li H; Zheng G
Cell Death Dis; 2019 May; 10(5):373. PubMed ID: 31073122
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
